References
- Diczfalusy E. Gregory Pincus and steroidal contraception: a new departure in the history of mankind. J Steroid Biochem 1979; 11(A): 3–11.
- Mishell DR. Non-contraceptive health benefits of oral steroidal contraceptives. Am J Obstet Gynaecol 1982; 142: 809–818.
- Fraser IS. Benefits and risks of steroidal contraception. In: Salamonsen L, editor. Hormones and women's health: the reproductive years. Amsterdam: Harwood Academic Publishers; 2000. p. 161–172.
- Kremser E, Mitchell GM. Treatment of primary dysmenorrhoea with a combined type oral contraceptive: a double-blind study. J Am Coll Health Assoc. 1971; 19: 195–9.
- Proctor ML, Roberts H, Farquhar C. Combined oral contraceptive pill (OCP) as treatment for primary dysmenorrhoea (Cochrane Review). In: The Cochrane Library. 2003; 2. Oxford: Update Software.
- Vercellini P, Trespidi L, Colomo A, et al. A gonadotro- phin-releasing hormone agonist versus a low-dose oral contraceptive for pelvis pain associated with endometriosis. Fertil Steril 1993; 60: 75–9.
- Nilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynaecol 1971; 110: 713–720.
- Lyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding (Cochrane Review). In: The Cochrane Library. 2003; 2. Oxford: Update Software.
- Peterson HB, Lee NC. The health effects of oral contraceptives: misperceptions, controversies and continuing good news. Clin Obstet Gynecol. 1989; 32: 339–355.
- Barth J, Cherry C, Wojnarowska F. Cyporoterone acetate for severe hirsutism: results of a double-blind dose-ranging study. J Clin Endocrinol Metab 1991; 35: 5–10.
- Keye WR. Premenstrual syndrome. In: Fraser IS, Jansen RPS, Lobo RA, Whitehead MI, editors. Estrogens and progestogens and clinical practice. London: Churchill Livingstone; 1998. p. 387–403.
- Archer DF, Maheux R, Del Conte A, O'Brien FB. A new low-dose monophasic combination oral contraceptive with levonorgestrel 100 μg and ethinyl oestradiol 20 μg. Contraception 1997; 55: 139–144.
- Grimes DA. Breast cancer, the pill and the press. In: Mann RD, editor. Oral contraceptives and breast cancer. Carnforth, UK: Parthenon Publishing; 1995. p. 309–322.
- Hickey M, Farquhar CM. Update on treatment of menstrual disorders. Med J Aust 2003; 426–9.
- Schlesselman JJ, Collins JA. The influence of steroids on gynaecologic cancers. In: Fraser IS, Jansen RPS, Lobo RA, Whitehead MI, editors. Estrogens and progestogens in clinical practice. London: Churchill Livingstone; 1998. p. 831–864.
- Rosenblatt KA, Thomas DB. Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer 1991; 49: 870–4.
- Drife JO. The benefits and risks of oral contraceptives today. 2nd ed. London: Parthenon Press; 1996.
- Bagwell MA, Coker AL, Thompson SJ, et al. Primary infertility and oral contraceptive steroid use. Fertil Steril 1995; 63: 1161–6.